In Situ Hybridization Market by Technology, End-user, and Geography - Forecast and Analysis 2021-2025

The in situ hybridization (ISH) market share is expected to increase by USD 475.05 million from 2020 to 2025, and the market’s growth momentum will accelerate at a CAGR of 7%.

The market research report provides valuable insights into the post-COVID-19 impact on the market, which will help companies evaluate their business approaches. Furthermore, this report extensively covers market segmentation by technology (FISH and CISH), end-user (molecular diagnostic laboratories, pharmaceutical and biotechnological companies, and others), and geography (North America, Europe, Asia, and ROW).

The in situ hybridization (ISH) market report also offers information on several market vendors, including Abbott Laboratories, Agilent Technologies Inc., Bio-Rad Laboratories Inc., Bio-Techne Corp., F. Hoffmann-La Roche Ltd., Merck KGaA, NeoGenomics Laboratories, Inc., PerkinElmer Inc., QIAGEN NV, and Thermo Fisher Scientific Inc. among others.

Abbott Laboratories - The company offers Vysis CEP 12 SpectrumOrange DNA Probe Kit among others. Under the established pharmaceuticals products segment, the company manufactures medicines for established and emerging markets. Under the nutritional products segment, the company offers a line of pediatric and adult nutritional products.

What will the In Situ Hybridization (ISH) Market Size be During the Forecast Period?

Get the In Situ Hybridization (ISH) Market Size Forecast by Downloading the Report Sample

Parent Market Analysis

Technavio categorizes the global in situ hybridization market as a part of the global life science tools and services market. Our research report extensively covers external factors influencing the parent market growth potential in the coming years, which will determine the levels of growth of the in situ hybridization (ISH) market during the forecast period.

In Situ Hybridization (ISH) Market: Key Drivers, Trends, and Challenges

Our researchers analyzed the data with 2022 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.

Key In Situ Hybridization (ISH) Market Driver

• One of the key factors driving growth in the in situ hybridization (ISH) market is the growing incidence and prevalence of cancer.
• The various types of cancers contribute to significant deaths across all regions of the world. However, low and middle-income countries are the worst-affected regions.
• The full array of interventions: surgery, radiotherapy, chemotherapy, and endocrine therapy is needed for many common cancers.
• As new cases of cancer forms emerge, they would be extremely crucial to diagnose and cure.
• Governments across the globe would want to reduce the huge economic burden caused by cancer on healthcare budgets, and this would drive the adoption of diagnosis through ISH, as it offers a faster and more accurate diagnosis of cancer, consequently resulting in the growth of the market.

Key In Situ Hybridization (ISH) Market Challenge

• The emergence of alternative techniques will be a major challenge for the in situ hybridization (ISH) market during the forecast period.
• Although FISH provides considerable cost-benefit and superior performance when compared with other molecular IVD tests, full-scale adoption of this technique lacks in routine IVD use. When applied to complex samples such as mucoid respiratory samples, results are highly irregular and the procedure is intrinsically complex.
• Certain challenges encountered while performing traditional FISH make it labour-intensive and time-consuming.
• With companies such as MetaSystems Indigo specifically involved in developing DMI, several other companies may follow suit and thereby affect the adoption rates of FISH and hinder the growth of the overall in situ hybridization market. 

This in situ hybridization (ISH) market analysis report also provides detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. The actionable insights on the trends and challenges will help companies evaluate and develop growth strategies for 2021-2025.

In Situ Hybridization (ISH) Market Value Chain Analysis

Our In-house experts produce extensive information on the value chain and parent market of the in situ hybridization (ISH) market, which vendors can leverage to gain a competitive advantage during the forecast period. The Value Chain information provides an end-to-end understanding of product insight and profit and also optimization and evaluation of business strategies. The players across the value chain include selective data and analysis from entire research findings as per the scope of the report.

Which are the Key Regions for In Situ Hybridization (ISH) Market?

Get a glance at the market share of various regions by Requesting a PDF Sample now!

43% of the market’s growth will originate from North America during the forecast period. The US is the key market for in situ hybridizations (ISH) in North America. Market growth in this region will be faster than the growth of the market in the European regions.

The growing incidence of diseases, such as cancer, which require molecular diagnosis, is also on the rise in these countries and thus contributes to the demand for ISH techniques. The US has also been at the centre of R&D of FISH probe technologies due to the increasing cases of cancer in the region. This will facilitate the in situ hybridization (ISH) market growth in North America over the forecast period. This market research report entails detailed information on the competitive intelligence, marketing gaps, and regional opportunities in store for vendors, which will assist in creating efficient business plans.

COVID Impact and Recovery Analysis

The rise in the incidence of COVID-19 in North America compelled governments to introduce emergency legislation, which included restrictions on several operational activities across industries. This led to the shutting down of several manufacturing units, including those of ISH products, in 2020. In addition, disruptions in the supply of raw materials required for manufacturing ISH products and the limited availability of workforce lowered the production volume of ISH products in North America in the first few months of 2020. However, the rising incidence of COVID-19 increased the demand for ISH products for diagnostic purposes, which, in turn, increased the demand for high production volume of ISH products from mid-2020. This, in turn, resulted in a moderate growth of the in situ hybridization market in North America in 2020. 

What is the Fastest-Growing Technology Segment in the In Situ Hybridization (ISH) Market?

To gain insights on the market contribution of various segments Request a PDF Sample

The in situ hybridization (ISH) market share growth by the FISH segment will be significant during the forecast period. FISH can detect cancer mutations, cancer-causing genes, as well as rare genetic disorders such as Angelman syndrome, Prader-Willi syndrome, acute lymphoblastic leukaemia, chronic myelogenous leukaemia, cri-du-chat disease, and Down syndrome. The prevalence of these rare diseases along with the high incidence and prevalence of cancer across the globe contributes to the higher demand for FISH in the market. Additionally, with the rising number of chromosomal defects among fetuses, an increasing number of expectant mothers are undergoing screening procedures to detect genetic abnormalities at an early stage.

This report provides an accurate prediction of the contribution of all the segments to the growth of the in situ hybridization (ISH) market size and actionable market insights on the post-COVID-19 impact on each segment.

 

In Situ Hybridization (ISH) Market Scope
Report Coverage	Details
Page number	120
Base year	2020
Forecast period	2021-2025
Growth momentum & CAGR	Accelerate at a CAGR of 7%
Market growth 2021-2025	$ 475.05 million
Market structure	Fragmented
YoY growth (%)	6.80
Regional analysis	North America, Europe, Asia, and ROW
Performing market contribution	North America at 43%
Key countries	US, Germany, Japan, France, and Australia
Competitive landscape	Leading companies, Competitive Strategies, Consumer engagement scope
Key companies profiled	Abbott Laboratories, Agilent Technologies Inc., Bio-Rad Laboratories Inc., Bio-Techne Corp., F. Hoffmann-La Roche Ltd., Merck KGaA, NeoGenomics Laboratories, Inc., PerkinElmer Inc., QIAGEN NV, and Thermo Fisher Scientific Inc.
Market dynamics	Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, Market condition analysis for the forecast period
Customization purview	If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Request PDF sample

What are the Key Data Covered in this In Situ Hybridization (ISH) Market Report?

• CAGR of the market during the forecast period
• Detailed information on factors that will drive in situ hybridization (ISH) market growth during the next five years
• Precise estimation of the in situ hybridization (ISH) market size and its contribution to the parent market
• Accurate predictions on upcoming trends and changes in consumer behaviour
• The growth of the in situ hybridization (ISH) market industry across North America, Europe, Asia, and ROW
• A thorough analysis of the market’s competitive landscape and detailed information on vendors
• Comprehensive analysis of factors that will challenge the growth of in situ hybridization (ISH) market vendors

We can help! Our analysts can customize this report to meet your requirements. Get in touch